triamcinolone acetonide has been researched along with cyclosporine in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (28.57) | 18.2507 |
| 2000's | 7 (33.33) | 29.6817 |
| 2010's | 7 (33.33) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Baulieu, EE; Handschumacher, RE; Hoffmann, K; Le Bihan, S; Mercier-Bodard, C; Ning, YM; Renoir, JM; Sanchez, ER | 1 |
| Färber, L; Iven, H; Sieg, P; Von Domarus, H; Von Zitzewitz, V | 1 |
| Duffill, MB | 1 |
| Cooper, KD; Elder, JT; Ellis, CN; Hammerberg, C; Kojima, T; Nair, RP; Voorhees, JJ | 1 |
| Lay, RH; Medh, RD; Schmidt, TJ | 1 |
| Fortin, D; Le Bihan, S; Marsaud, V; Mercier-Bodard, C; Renoir, JM | 1 |
| de Berker, D | 1 |
| el-Garhy, MF; el-Hamshary, E; el-Shazly, AM; el-Shewey, K; Habib, FS; Morsy, TA | 1 |
| Ahmed, S; Bee, WH; Chaimusik, M; Kim, MJ; Machin, D; Rajaseharan, A; Seldrup, J; Suresh, S; Thongprasom, K; Tin, GB; Yoke, PC | 1 |
| Chaimusig, M; Korkij, W; Luangjarmekorn, L; Rojwattanasirivej, S; Sererat, T; Thongprasom, K | 1 |
| Cakir, H; Kaya, V; Perente, I; Tutkun, IT; Utine, CA; Yilmaz, OF | 1 |
| Alkhalifah, A; Alsantali, A; McElwee, KJ; Shapiro, J; Wang, E | 1 |
| Aoun, B; Ulinski, T | 1 |
| Folk, JC; Jakovic, N; Jaksic, VZ; Milenkovic, SM; Paovic, JD; Risimic, DS; Stefanovic, IB | 1 |
| Balaskas, K; Eperon, S; Guex-Crosier, Y; Gurny, R; Rodriguez-Aller, M | 1 |
| Ashraf, M; Choi, S; Cruz, CN; Dong, Y; Hengst, L; Hunt, R; Patel, D; Qu, H; Xu, X | 1 |
| Ando, Y; Hayashi, I; Keino, H; Nakayama, M; Okada, AA; Watanabe, T | 1 |
5 review(s) available for triamcinolone acetonide and cyclosporine
| Article | Year |
|---|---|
Topical cyclosporin in oral lichen planus: a controlled, randomized, prospective trial.
Topics: Administration, Topical; Adult; Aged; Cyclosporine; Female; Humans; Lichen Planus; Male; Middle Aged; Mouth Diseases; Prospective Studies; Triamcinolone Acetonide | 1995 |
Management of nail psoriasis.
Topics: Administration, Topical; Anti-Inflammatory Agents; Antifungal Agents; Cyclosporine; Dermatologic Agents; Female; Fluorouracil; Glucocorticoids; Humans; Keratosis; Male; Methotrexate; Nail Diseases; Psoriasis; Triamcinolone Acetonide | 2000 |
Drugs for some common eye disorders.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antioxidants; Carbonic Anhydrase Inhibitors; Cholinergic Agonists; Conjunctivitis, Allergic; Conjunctivitis, Bacterial; Cyclosporine; Diuretics, Osmotic; Dry Eye Syndromes; Eye Diseases; Glaucoma; Glucocorticoids; Humans; Immunosuppressive Agents; Macular Degeneration; Ophthalmic Solutions; Patient Compliance; Patient Selection; Photochemotherapy; Prostaglandins; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Zinc | 2007 |
Alopecia areata update: part II. Treatment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Alopecia Areata; Animals; Child; Cyclopropanes; Cyclosporine; Hair; Haptens; Humans; Immunotherapy; Injections, Intralesional; Laser Therapy; Methotrexate; Minoxidil; Photochemotherapy; Randomized Controlled Trials as Topic; Rats; Recurrence; Research Design; Social Support; Sulfasalazine; Treatment Outcome; Triamcinolone Acetonide | 2010 |
Pediatric idiopathic nephrotic syndrome: treatment strategies in steroid dependent and steroid resistant forms.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Child; Cyclosporine; Enzyme Inhibitors; Humans; Immunosuppressive Agents; Levamisole; Mycophenolic Acid; Nephrotic Syndrome; Rituximab; Steroids; Tacrolimus; Triamcinolone Acetonide | 2010 |
3 trial(s) available for triamcinolone acetonide and cyclosporine
| Article | Year |
|---|---|
Topical cyclosporin in oral lichen planus: a controlled, randomized, prospective trial.
Topics: Administration, Topical; Adult; Aged; Cyclosporine; Female; Humans; Lichen Planus; Male; Middle Aged; Mouth Diseases; Prospective Studies; Triamcinolone Acetonide | 1995 |
A randomized controlled trial to compare steroid with cyclosporine for the topical treatment of oral lichen planus.
Topics: Administration, Topical; Adolescent; Adult; Aged; Carboxymethylcellulose Sodium; Child; Cyclosporine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lichen Planus, Oral; Male; Middle Aged; Odds Ratio; Pain Measurement; Patient Satisfaction; Regression Analysis; Treatment Outcome; Triamcinolone Acetonide | 2006 |
A randomized-controlled trial to compare topical cyclosporin with triamcinolone acetonide for the treatment of oral lichen planus.
Topics: Administration, Topical; Adult; Aged; Chi-Square Distribution; Cyclosporine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lichen Planus, Oral; Male; Middle Aged; Pain Measurement; Statistics, Nonparametric; Triamcinolone Acetonide | 2007 |
14 other study(ies) available for triamcinolone acetonide and cyclosporine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Cyclosporin A potentiates the dexamethasone-induced mouse mammary tumor virus-chloramphenicol acetyltransferase activity in LMCAT cells: a possible role for different heat shock protein-binding immunophilins in glucocorticosteroid receptor-mediated gene e
Topics: Animals; Chloramphenicol O-Acetyltransferase; Cyclosporine; Cytosol; Dexamethasone; Drug Synergism; Gene Expression; L Cells; Mammary Tumor Virus, Mouse; Mice; Receptors, Glucocorticoid; Recombinant Proteins; Tacrolimus; Transcription, Genetic; Transfection; Triamcinolone Acetonide | 1995 |
Cyclosporine, azathioprine and local therapy for pyoderma gangrenosum.
Topics: Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Humans; Injections, Intralesional; Middle Aged; Pyoderma Gangrenosum; Severity of Illness Index; Triamcinolone Acetonide; Wound Healing | 1994 |
Cyclosporin A rapidly inhibits epidermal cytokine expression in psoriasis lesions, but not in cytokine-stimulated cultured keratinocytes.
Topics: Blotting, Northern; Cells, Cultured; Cyclosporine; Cytokines; Enzyme-Linked Immunosorbent Assay; Gene Expression; Humans; Interleukin-1; Keratinocytes; Psoriasis; RNA, Messenger; Skin; Triamcinolone Acetonide | 1993 |
Agonist-specific modulation of glucocorticoid receptor-mediated transcription by immunosuppressants.
Topics: Animals; Corticosterone; Cortodoxone; Cyclosporine; Desoxycorticosterone; Dexamethasone; Genes, Reporter; Glucocorticoids; Hydrocortisone; Immunosuppressive Agents; L Cells; Luciferases; Mice; Polyenes; Quinidine; Receptors, Glucocorticoid; Recombinant Fusion Proteins; Sirolimus; Tacrolimus; Transcription, Genetic; Transfection; Triamcinolone Acetonide; Verapamil | 1998 |
Dexamethasone and triamcinolone acetonide accumulation in mouse fibroblasts is differently modulated by the immunosuppressants cyclosporin A, FK506, rapamycin and their analogues, as well as by other P-glycoprotein ligands.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line; Cyclosporine; Dexamethasone; Gene Expression Regulation; Genes, Reporter; Glucocorticoids; Immunosuppressive Agents; Mice; Polyenes; Receptors, Glucocorticoid; Sirolimus; Steroids; Tacrolimus; Transfection; Triamcinolone Acetonide; Vinca Alkaloids | 1998 |
Mice immunzation using crude Trichinella spiralis antigen.
Topics: Animals; Antigens, Helminth; Cyclophosphamide; Cyclosporine; Immunization; Immunosuppressive Agents; Larva; Male; Mice; Treatment Outcome; Triamcinolone Acetonide; Trichinella spiralis; Trichinellosis | 2002 |
Management of ocular complications of Vogt-Koyanagi-Harada syndrome.
Topics: Adolescent; Cyclosporine; Drug Therapy, Combination; Eye Diseases; Female; Fluorescein Angiography; Glucocorticoids; Humans; Immunosuppressive Agents; Optic Nerve Diseases; Retinal Detachment; Tomography, Optical Coherence; Triamcinolone Acetonide; Ultrasonography; Uveomeningoencephalitic Syndrome; Vitreous Body | 2009 |
Diagnostic and therapeutic challenges.
Topics: Choroiditis; Cyclosporine; Drug Therapy, Combination; Fluorescein Angiography; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Triamcinolone Acetonide; Vision Disorders; Visual Acuity | 2010 |
A new drug delivery system inhibits uveitis in an animal model after cataract surgery.
Topics: Animals; Anti-Inflammatory Agents; Biocompatible Materials; Cataract Extraction; Cyclosporine; Disease Models, Animal; Drug Carriers; Drug Combinations; Drug Delivery Systems; Female; Lactic Acid; Lens Implantation, Intraocular; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Triamcinolone Acetonide; Uveitis | 2013 |
A Kinetic Approach to Determining Drug Distribution in Complex Biphasic Systems.
Topics: Chemistry, Pharmaceutical; Cyclosporine; Diffusion; Drug Liberation; Emulsions; Fluprednisolone; Micelles; Solvents; Therapeutic Equivalency; Triamcinolone Acetonide; Water | 2019 |
A COVID-19 Risk Reduction Strategy for the Treatment of Acute Vogt-Koyanagi-Harada Disease Utilizing the Antiviral Potential of Cyclosporine.
Topics: Aged; COVID-19; Cyclosporine; Glucocorticoids; Humans; Pandemics; Retrospective Studies; Triamcinolone Acetonide; Uveomeningoencephalitic Syndrome | 2023 |